These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3375288)

  • 1. A critical approach to the study of new agents for the prevention of arterial thrombosis: a comment.
    Prosdocimi M; Finesso M; Dejana E
    Pharmacol Res Commun; 1988 Jan; 20(1):1-6. PubMed ID: 3375288
    [No Abstract]   [Full Text] [Related]  

  • 2. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.
    Nurden AT
    Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for endothelium friendly stents.
    McCormick C
    Med Device Technol; 2007; 18(3):30, 32-3. PubMed ID: 17585718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation and stent thrombosis.
    Georgiadou P; Voudris V
    Hellenic J Cardiol; 2017; 58(1):49-50. PubMed ID: 28396052
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.
    Warner TD; Armstrong PC; Chan MV; Knowles RB
    Expert Rev Hematol; 2016 Mar; 9(3):223-5. PubMed ID: 26822235
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of pharmacologic agents on crush-avulsion arterial injuries: a scanning electron microscopy study.
    Savoie FH; Cooley BC; Gould JS
    Microsurgery; 1991; 12(4):292-300. PubMed ID: 1716720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis.
    Diskin CJ; Stokes TJ; Pennell AT
    Nephron; 1993; 64(1):1-26. PubMed ID: 8502311
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of arterial thrombosis by edoxaban, an oral factor Xa inhibitor in rats: monotherapy and in combination with antiplatelet agents.
    Honda Y; Kamisato C; Morishima Y
    Eur J Pharmacol; 2016 Sep; 786():246-252. PubMed ID: 27288116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of stent thrombosis: platelet activation, mechanical factors, or both?
    Alfonso F
    J Am Coll Cardiol; 2006 Mar; 47(5):1086-7; author reply 1087. PubMed ID: 16516100
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.
    Wilson JM; Ferguson JJ
    Clin Cardiol; 1999 Nov; 22(11):687-98. PubMed ID: 10554682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
    Hupkens P; Cooley BC
    Microsurgery; 1996; 17(4):226-9. PubMed ID: 9140956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of platelet activation and development of antiplatelet agents].
    Cazenave JP; Gachet C; Lanza F
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo.
    Metzig C; Grabowska E; Eckert K; Rehse K; Maurer HR
    In Vivo; 1999; 13(1):7-12. PubMed ID: 10218125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium.
    Buchanan MR; Brister SJ; Ofosu F
    Wien Klin Wochenschr; 1993; 105(11):309-13. PubMed ID: 8333198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial thrombosis as a sequela of flow anomalies--activation of the hemostatic system and endothelial damage].
    Wurzinger LJ
    Vasa Suppl; 1991; 32():43-53. PubMed ID: 1771552
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
    Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.